carbon-11 acetate
Small moleculeexperimental
Clinical trial activity
3 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 31, 2010 (NCT01144897)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Payload
- 11-carbon
Oral
No
Parenteral
No
Topical
No
Also known as
- (11c)-acetate
- carbon-11 acetate
- carbon-11 acetate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02169063 | N/A | Dec 1, 2015 | National Cancer Institute (NCI), University of Washington |
| NCT02379377 | N/A | Mar 1, 2015 | National Cancer Institute (NCI), Vanderbilt University |
| NCT01144897 | Phase 1 | May 31, 2010 | University of Iowa |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Cancer Institute (NCI) | Government | 2 | 0 | 1 | 2015 |
| University of Iowa | Academic/Hospital | 1 | 1 | 1 | 2010 |
| University of Washington | Academic/Hospital | 1 | 1 | 1 | 2015 |
| Vanderbilt University | Academic/Hospital | 1 | 1 | 1 | 2015 |
4 organizations
Page 1 / 1